Cite
Albanese L, Caliendo G, D'Elia G, et al. Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease. J Circ Biomark. 2022;11:1-4doi: 10.33393/jcb.2022.2328.
Albanese, L., Caliendo, G., D'Elia, G., Passariello, L., Molinari, A. M., Napoli, C., & Vietri, M. T. (2022). Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease. Journal of circulating biomarkers, 111-4. https://doi.org/10.33393/jcb.2022.2328
Albanese, Luisa, et al. "Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease." Journal of circulating biomarkers vol. 11 (2022): 1-4. doi: https://doi.org/10.33393/jcb.2022.2328
Albanese L, Caliendo G, D'Elia G, Passariello L, Molinari AM, Napoli C, Vietri MT. Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease. J Circ Biomark. 2022 Jan 08;11:1-4. doi: 10.33393/jcb.2022.2328. eCollection 2022. PMID: 35023876; PMCID: PMC8749389.
Copy
Download .nbib